Treatment with vonoprazan for 3 weeks is not inferior to 8 weeks for the management of gastric ESD:...
Treatment with vonoprazan for 3 weeks is not inferior to 8 weeks for the management of gastric ESD: a multicenter noninferiority randomized study
About this item
Full title
Author / Creator
Kato, Motohiko , Hosoe, Naoki , Gotoda, Takuji , Kusano, Chika , Kuramochi, Mizuki , Yoshida, Hideo , Kimoto, Yoshiaki , Okamura, Yukishige , Imaeda, Hiroyuki , Ito, Takafumi , Miyamoto, Yasuo , Horii, Toshiki , Mori, Hideki , Morohoshi, Yuichi , Ohno, Akiko , Kishino, Ryohei , Kubosawa, Yoko , Yoshimura, Kenichi , Yahagi, Naohisa and Kanai, Takanori
Publisher
Singapore: Springer Nature Singapore
Journal title
Language
English
Formats
Publication information
Publisher
Singapore: Springer Nature Singapore
Subjects
More information
Scope and Contents
Contents
Background
Vonoprazan
, a potassium-competitive acid blocker (VPZ), significantly reduces postoperative bleeding after gastric ESD; however, there is no consensus on the appropriate treatment duration. We conducted a randomized controlled study to demonstrate that the 3-week administration of VPZ is not inferior to the 8-week administration f...
Alternative Titles
Full title
Treatment with vonoprazan for 3 weeks is not inferior to 8 weeks for the management of gastric ESD: a multicenter noninferiority randomized study
Authors, Artists and Contributors
Author / Creator
Hosoe, Naoki
Gotoda, Takuji
Kusano, Chika
Kuramochi, Mizuki
Yoshida, Hideo
Kimoto, Yoshiaki
Okamura, Yukishige
Imaeda, Hiroyuki
Ito, Takafumi
Miyamoto, Yasuo
Horii, Toshiki
Mori, Hideki
Morohoshi, Yuichi
Ohno, Akiko
Kishino, Ryohei
Kubosawa, Yoko
Yoshimura, Kenichi
Yahagi, Naohisa
Kanai, Takanori
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2776517502
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2776517502
Other Identifiers
ISSN
0944-1174
E-ISSN
1435-5922
DOI
10.1007/s00535-023-01966-z
